Vivek Ramaswamy
Vivek Ramaswamy's purchase track record
Vivek Ramaswamy has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/5/2025 | ASST | $1.25M | -59.5% | -44.3% | +8.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
ASST Announces Preferred Stock IPO to Fund $280M Bitcoin Purchase. Strive announced an initial public offering of 5 million shares of its 15 % Series A perpetual SATS preferred stock. The proceeds are intended to finance a $280 million bitcoin purchase, the company’s largest in months, and it also exercised $369.2 million of warrants during the same period. The move follows broader market discussion about inflation’s impact on crypto and comments from Michael Saylor noting the scale of the purchase.
Transaction History
| ROIV | ▲ Buy | Option Exercise | 832,453 | $10.6M | 12/15/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 353,745 | $7.8M | 12/15/2025 | View on chart |
| ROIV | ▼ Sell | Other | 478,708 | $10.6M | 12/15/2025 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 4,672,724 | $59.3M | 12/12/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 1,975,858 | $43.4M | 12/12/2025 | View on chart |
| ROIV | ▼ Sell | Other | 2,696,866 | $59.2M | 12/12/2025 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 1,869,691 | $23.7M | 12/11/2025 | View on chart |
| ROIV | ▼ Sell | Other | 1,095,550 | $23.7M | 12/11/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 774,142 | $16.8M | 12/11/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 539,650 | $11.1M | 11/17/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 1,027,670 | $20.9M | 11/14/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 287,283 | $6.0M | 11/13/2025 | View on chart |
| ASST | ▲ Buy | Open Market | 15,625 | $1.3M | 11/5/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 385,816 | $5.0M | 9/5/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 194,933 | $2.5M | 9/4/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 1,195,000 | $14.9M | 9/3/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 577,007 | $6.6M | 6/20/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 565,266 | $6.5M | 6/18/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 200,800 | $2.2M | 6/6/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 547,430 | $6.2M | 6/4/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 625,000 | $7.0M | 5/7/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 273,959 | $3.1M | 5/6/2025 | View on chart |
| ROIV | ▼ Sell | Gift | 13,357,857 | $0 | 1/23/2025 | View on chart |
| ROIV | ▼ Sell | Gift | 13,357,857 | $0 | 1/23/2025 | View on chart |
| ROIV | ▼ Sell | Open Market | 3,000,000 | $33.2M | 1/2/2024 | View on chart |
| ROIV | ▼ Sell | Tax Withholding | 133,911 | $1.6M | 12/27/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 275,227 | — | 12/27/2023 | View on chart |
| ROIV | ▼ Sell | Other | 61,947 | $785K | 9/28/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 119,534 | — | 9/27/2023 | View on chart |
| ROIV | ▼ Sell | Other | 47,692 | $537K | 8/28/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 86,714 | — | 8/27/2023 | View on chart |
| ROIV | ▼ Sell | Other | 76,023 | $869K | 7/31/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 166,057 | — | 7/27/2023 | View on chart |
| ROIV | ▼ Sell | Other | 189,947 | $1.7M | 5/31/2023 | View on chart |
| ROIV | ▲ Buy | Option Exercise | 382,203 | — | 5/27/2023 | View on chart |
| ROIV | ▼ Sell | Open Market | 4,000,000 | $31.8M | 2/22/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roivant Sciences receives downgrades from Wolfe Research and analyst
Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.
Roivant Sciences receives downgrades from Wolfe Research and analyst. Wolfe Research lowered Roivant Sciences to a peer‑perform rating. In the same week, an analyst who had been bullish on the company removed that stance, placing Roivant among a list of recent downgrades. The stock is now trading near its $28.03 support level with an RSI below 40, indicating limited upward momentum.